KRON Kronos Bio, Inc.: institutional ownership and insider trading
Over the last 12 months insiders bought $0 and sold $0 on the open market; over its last four quarters it reported revenue of $9.19M and net income of −$64.5M.
KRON revenue and earnings
- Quarter ended Mar 31, 2025: revenue $1.86M, net income −$8.36M, EPS -0.14
- Quarter ended Dec 31, 2024: revenue $2.27M, net income −$25.8M, EPS -0.43
- Quarter ended Sep 30, 2024: revenue $2.37M, net income −$14.1M, EPS -0.23
- Quarter ended Jun 30, 2024: revenue $2.69M, net income −$16.2M, EPS -0.27
Recent KRON insider trades
- Jun 5, 2025: Knobelman Deborah sold 24,838 shares ($21.6K)
Are insiders buying or selling KRON?
No open-market insider buys or sells of Kronos Bio, Inc. were reported in the last 12 months.
What was KRON's revenue last quarter?
Kronos Bio, Inc. reported revenue of $1.86M for the quarter ended March 31, 2025, with net income of −$8.36M.